References
- Agashe HB, Dutta T, Garg M, Jain NK. (2006). Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer. J Pharm Pharmacol, 58, 1491–1498.
- Ahmad Z, Pandey R, Sharma S, Khuller GK. (2008). Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles. Int J Antimicrob Agents, 31, 142–146.
- Coester CJ, Langer K, Van-Briesen H, Kreuter J. (2000). Gelatin nanoparticles by two-step desolvation—a new preparation method, surface modifications and cell uptake. J Microencap, 17, 187–193.
- Couvreur P, Fattal E, Andremont A. (1991). Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm Res, 8, 1079–1086.
- Davis BG, Robinson MA. (2002). Drug delivery systems based on sugar macromolecule conjugates. Curr Opin Drug Discov Dev, 5, 279–288.
- Deol P, Khuller GK. (1997). Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim Biophys Acta, 1334, 161–172.
- Desiderio JV, Campbell SG. (1983). Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis. J Reticuloendothel Soc, 34, 279–287.
- Gaspar MM, Cruz A, Penha AF, Reymão J, Sousa AC, Eleutério CV, Domingues SA, Fraga AG, Filho AL, Cruz ME, Pedrosa J. (2008). Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis. Int J Antimicrob Agents, 31, 37–45.
- Gelperina S, Kisich K, Iseman MD, Heifets L. (2005). The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med, 172, 1487–1490.
- Guillaumont M, Leclercq M, Frobert Y, Guise B, Harf R. (1982). Determination of rifampicin, desacetylrifampicin, isoniazid and acetylisoniazid by high-performance liquid chromatography: application to human serum extracts, polymorphonucleocytes and alveolar macrophages. J Chromatogr, 232, 369–376.
- Jain SK, Gupta Y, Jain A, Saxena AR, Khare P, Jain A. (2008). Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine, 4, 41–48.
- Kaur A, Jain S, Tiwary AK. (2008). Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation. Acta Pharm, 58, 61–74.
- Kumar PV, Asthana A, Dutta T, Jain NK. (2006). Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target, 14, 546–556.
- Nahar M, Mishra D, Dubey V, Jain NK. (2008). Development, characterization, and toxicity evaluation of amphotericin B–loaded gelatin nanoparticles. Nanomed Nanotech Biology Med, 4, 252–261.
- Nimje N, Agarwal A, Saraogi GK, Lariya N, Rai G, Agrawal H, Agrawal GP. (2009). Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. J Drug Target, 17, 777–787.
- Pandey R, Sharma S, Khuller GK. (2006). Chemotherapeutic efficacy of nanoparticle encapsulated antitubercular drugs. Drug Deliv, 13, 287–294.
- Saraogi GK, Gupta P, Gupta UD, Jain NK, Agrawal GP. (2010). Gelatin nanocarriers as potential vectors for effective management of tuberculosis. Int J Pharm, 385, 143–149.
- Sharma A, Sharma S, Khuller GK. (2004). Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. J Antimicrob Chemother, 54, 761–766.
- Swenson CE, Stewart KA, Hammett JL, Fitzsimmons WE, Ginsberg RS. (1990). Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin. Antimicrob Agents Chemother, 34, 235–240.
- du Toit LC, Pillay V, Danckwerts MP. (2006). Tuberculosis chemotherapy: current drug delivery approaches. Respir Res, 7, 118.
- Uto T, Wang X, Sato K, Haraguchi M, Akagi T, Akashi M, Baba M. (2007). Targeting of Antigen to Dendritic Cells with Poly (γ glutamic acid) nanoparticles induces antigen specific humoral and cellular immunity. J Imm, 178, 2979–2986.
- van den Broek PJ, Buys LF, van den Barselaar MT, Leijh PC, van Furth R. (1986). Influence of human monocytes on the antibacterial activity of kanamycin and gentamicin for Staphylococcus aureus. Antimicrob Agents Chemother, 29, 1032–1039.
- Vandervoort J, Ludwig A. (2004). Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur J Pharm Biopharm, 57, 251–261.
- WHO. (2008). Global Tuberculosis Control Surveillance, Planning, Financing. http://www.who.int/tb/publications/global_report/2008/pdf/fullreport.pdf (Accessed 30 April 2009).
- Zahoor A, Pandey R, Sharma S, Khuller GK. (2006). Evaluation of antitubercular drug loaded alginate nanoparticles against experimental tuberculosis. J Nanoscience, 1, 81–85.